After big gains, Cystic Fibrosis Foundation bankrolls research toward cures — and drugs for those left out
Last week, the cystic fibrosis community celebrated the approval of another new drug for patients. But, advocates say, much work remains to be done.
Last week, the cystic fibrosis community celebrated the approval of a new drug from Vertex Pharmaceuticals, a decision that offers the large majority of patients access to cutting-edge treatments.
Those treatments, however, don’t cover patients with certain rare mutations. And they are not cures for anyone.
Seeking to address those issues, the Cystic Fibrosis Foundation on Wednesday unveiled a $500 million initiative aimed at developing treatments for and, ultimately, at finding cures for all CF patients. The message is: Despite
